Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Hospital Use Only” OTC Line Considered By Novartis For Bar Code Reg

This article was originally published in The Tan Sheet

Executive Summary

Novartis Consumer Healthcare is considering developing a "hospital use only" line of OTC drugs to comply with FDA's new bar code regulations

You may also be interested in...



FDA Oversight Among Hot Button Issues In 112th Congress

Health care reform and oversight of FDA remain hot button issues in the 112th Congress, industry advocates say.

OTCs Covered Under Bar Code Proposed Rule Clarification Requested By CHPA

The Consumer Healthcare Products Association requests FDA clarify which OTCs "dispensed under an order" would be covered as part of the agency's proposed rule requiring bar codes on drug products

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel